Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.

The School of Biological Sciences associate professor will be digging deep into itch-sensing neural circuits to gain insights into how the sensory system is wired — and where best to treat it when things go wrong.

The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.

Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.

Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition

Andrew Rogers was given a week to live at 3 years old. Now cancer-free, he wants to make sure no child with cancer goes through it alone.

Georgia Tech Researcher Simon Sponberg collaborates to ask why robotic advancements have yet to outpace animals — and look at what we can learn from biology to engineer new robotic designs.

Exercise is good for you. To understand why, MoTrPAC scientists are creating a whole-body map of molecular responses to endurance training — finding striking “all tissue effects” in a new set of studies, featured on the May cover of the journal Nature.

First phase of innovation district promises to encourage medical advances, drive economic growth, and inspire future generations

Fenton has spent the last 30 years using physics to better understand how the heart functions, and has made groundbreaking contributions to the field.